Experienced in Movement Disorders

Dr. Souheil Moussly

Internal Medicine
Ebenezer Medical Center Orlando Corp.
845 E Oak St, 
Kissimmee, FL 
Accepting New Patients
Experienced in Movement Disorders
Ebenezer Medical Center Orlando Corp.
845 E Oak St, 
Kissimmee, FL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Souheil Moussly is a primary care provider, practicing in Internal Medicine in Kissimmee, Florida. Dr. Moussly is rated as an Experienced provider by MediFind in the treatment of Movement Disorders. His top areas of expertise are Enlarged Prostate (BPH), Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, and Hypertension. Dr. Moussly is currently accepting new patients.

His clinical research consists of participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Internal Medicine
Licenses
Internal Medicine in FL
Languages Spoken
English
Arabic
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Health First
  • HMO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Sunshine Health
  • EPO
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 3 Less Insurance Carriers -

Locations

EBENEZER MEDICAL CENTER ORLANDO CORP.
845 E Oak St, Kissimmee, FL 34744

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)
Enrollment Status: Completed
Publish Date: October 14, 2025
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Open-Label Extension Study to Evaluate the Long Term Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis LUCENT 3
A Phase 3, Multicenter, Open-Label Extension Study to Evaluate the Long Term Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis LUCENT 3
Enrollment Status: Active_not_recruiting
Publish Date: October 10, 2025
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Enrollment Status: Completed
Publish Date: May 31, 2025
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Open-Label, Long-Term Extension Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Patients With Crohn's Disease
A Phase 3, Multicenter, Open-Label, Long-Term Extension Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Patients With Crohn's Disease
Enrollment Status: Active_not_recruiting
Publish Date: April 18, 2025
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
Enrollment Status: Completed
Publish Date: December 27, 2024
Intervention Type: Drug
Study Drugs: Mirikizumab, Ustekinumab
Study Phase: Phase 3
View 4 Less Clinical Trials
Similar Doctors
Advanced in Movement Disorders
Dr. Nibha Mediratta
Internal Medicine
Advanced in Movement Disorders
Dr. Nibha Mediratta
Internal Medicine

Nibha Mediratta MD Pl

1950 Hospital View Way, 
Clermont, FL 
 (29.5 miles away)
321-274-1864
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Nibha Mediratta is a primary care provider, practicing in Internal Medicine in Clermont, Florida. Dr. Mediratta is rated as a Distinguished provider by MediFind in the treatment of Movement Disorders. Her top areas of expertise are Hypothyroidism, Obesity in Children, Peptic Ulcer, and Coronary Heart Disease. Dr. Mediratta is currently accepting new patients.

Advanced in Movement Disorders
Dr. Pankil A. Patel
Internal Medicine
Advanced in Movement Disorders
Dr. Pankil A. Patel
Internal Medicine

Orlando Health Medical Group Inc

86 W Underwood St, 
Orlando, FL 
 (15.9 miles away)
407-896-1100
Languages Spoken:
English, Hindi
See accepted insurances
Accepting New Patients

Pankil Patel is a primary care provider, practicing in Internal Medicine in Orlando, Florida. Dr. Patel is rated as an Advanced provider by MediFind in the treatment of Movement Disorders. His top areas of expertise are Movement Disorders, Parkinson's Disease, Familial Neurocardiogenic Syncope, Pacemaker Implantation, and Coronary Artery Bypass Graft (CABG). Dr. Patel is currently accepting new patients.

Advanced in Movement Disorders
Dr. Alexander C. Mbakwem
Internal Medicine
Advanced in Movement Disorders
Dr. Alexander C. Mbakwem
Internal Medicine

Alexander C Mbakwem MD PA

1629 Lakeland Hills Blvd, 
Lakeland, FL 
 (41.3 miles away)
863-687-9333
Languages Spoken:
English, Bahasa
See accepted insurances
Accepting New Patients

Alexander Mbakwem is a primary care provider, practicing in Internal Medicine in Lakeland, Florida. Dr. Mbakwem is rated as an Advanced provider by MediFind in the treatment of Movement Disorders. His top areas of expertise are Anemia, Movement Disorders, Parkinson's Disease, Gastrostomy, and Endoscopy. Dr. Mbakwem is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Moussly's expertise for a condition
ConditionClose
      View All 87 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile